Literature DB >> 2971675

Defective expression of the 2H4 molecule after autologous mixed lymphocyte reaction activation in systemic lupus erythematosus patients.

T Takeuchi1, S Tanaka, A D Steinberg, T Matsuyama, J Daley, S F Schlossman, C Morimoto.   

Abstract

Previous studies demonstrated that patients with active systemic lupus erythematosus (SLE), especially those with active renal disease, had a marked reduction in T4+2H4+ suppressor inducer cells in their peripheral blood. However, it was puzzling to find that active SLE patients without renal diseases often had normal percentages of T4+2H4+ cells. In the present study, we attempted to determine whether active SLE patients bearing normal percentages of T4+2H4+ cells had a defect in their expression of the 2H4 molecule on T4+ cells after autologous mixed lymphocyte reaction (AMLR) activation. The peripheral blood lymphocytes (PBL) from 50 SLE patients with normal percentages of T4+2H4+ cells (greater than or equal to 7% in PBL) were studied and the results were compared with those of 40 normal individuals. The density of the 2H4 molecule on T4 cells from normal controls increased during the 7-d AMLR; in contrast T4 cells from patients with SLE, especially those with active SLE, had defective expression of the 2H4 antigen after AMLR activation. Patients with inactive SLE, like normals, showed an increase in the 2H4 molecule after AMLR activation. Moreover, a strong correlation was observed between percent suppression of pokeweed mitogen (PWM)-driven IgG synthesis and the density of the 2H4 antigen on AMLR-activated T4 cells. Serial analysis of patients with SLE showed that the density of the 2H4 antigen expression and the suppressor inducer activity of AMLR-activated T4 cells were inversely correlated with disease activity. Thus, defective expression of the 2H4 antigen may be an important mechanism for the failure of active SLE patients with normal percentages of T4+2H4+ cells to generate suppression.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2971675      PMCID: PMC442681          DOI: 10.1172/JCI113728

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  Activation of human thymocytes via the 50KD T11 sheep erythrocyte binding protein induces the expression of interleukin 2 receptors on both T3+ and T3- populations.

Authors:  D A Fox; R E Hussey; K A Fitzgerald; A Bensussan; J F Daley; S F Schlossman; E L Reinherz
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

2.  The cellular basis for the induction of antigen-specific T8 suppressor cells.

Authors:  C Morimoto; N L Letvin; J A Distaso; H M Brown; S F Schlossman
Journal:  Eur J Immunol       Date:  1986-02       Impact factor: 5.532

3.  The role of the 2H4 molecule in the generation of suppressor function in Con A-activated T cells.

Authors:  C Morimoto; N L Letvin; C E Rudd; M Hagan; T Takeuchi; S F Schlossman
Journal:  J Immunol       Date:  1986-11-15       Impact factor: 5.422

4.  Induction of suppression following autologous mixed lymphocyte reaction; role of a novel 2H4 antigen.

Authors:  T Takeuchi; C E Rudd; S F Schlossman; C Morimoto
Journal:  Eur J Immunol       Date:  1987-01       Impact factor: 5.532

Review 5.  A monoclonal antibody that blocks class II histocompatibility-related immune interactions.

Authors:  R F Todd; S C Meuer; P L Romain; S F Schlossman
Journal:  Hum Immunol       Date:  1984-05       Impact factor: 2.850

6.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

7.  T lymphocyte interaction with immunoglobulin G antibody in systemic lupus erythematosus.

Authors:  K Okudaira; R P Searles; K Tanimoto; Y Horiuchi; R C Williams
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

Review 8.  Anti-lymphocyte antibodies in systemic lupus erythematosus.

Authors:  J B Winfield
Journal:  Clin Rheum Dis       Date:  1985-12

9.  The isolation and characterization of the human suppressor inducer T cell subset.

Authors:  C Morimoto; N L Letvin; J A Distaso; W R Aldrich; S F Schlossman
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

10.  A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody.

Authors:  C Morimoto; A D Steinberg; N L Letvin; M Hagan; T Takeuchi; J Daley; H Levine; S F Schlossman
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

View more
  6 in total

1.  Abnormalities of T lymphocyte subsets in systemic sclerosis demonstrated with anti-CD45RA and anti-CD29 monoclonal antibodies.

Authors:  A Kahan; A Kahan; F Picard; C J Menkès; B Amor
Journal:  Ann Rheum Dis       Date:  1991-06       Impact factor: 19.103

Review 2.  Antibodies to CD45 and other cell membrane antigens in systemic lupus erythematosus.

Authors:  J B Winfield; P Fernsten; J Czyzyk; E Wang; J Marchalonis
Journal:  Springer Semin Immunopathol       Date:  1994

Review 3.  TCRzeta mRNA splice variant forms observed in the peripheral blood T cells from systemic lupus erythematosus patients.

Authors:  Kensei Tsuzaka; Kyoko Nozaki; Chika Kumazawa; Kiyono Shiraishi; Yumiko Setoyama; Keiko Yoshimoto; Tohru Abe; Tsutomus Takeuchi
Journal:  Springer Semin Immunopathol       Date:  2006-09-05

4.  Defective expression and tyrosine phosphorylation of the T cell receptor zeta chain in peripheral blood T cells from systemic lupus erythematosus patients.

Authors:  M Pang; Y Setoyama; K Tsuzaka; K Yoshimoto; K Amano; T Abe; T Takeuchi
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

5.  Upregulated expression and function of integrin adhesive receptors in systemic lupus erythematosus patients with vasculitis.

Authors:  T Takeuchi; K Amano; H Sekine; J Koide; T Abe
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

6.  Analysis of bone marrow and peripheral blood immunoregulatory lymphocytes in patients with myelodysplastic syndrome.

Authors:  O Iwase; S Aizawa; Y Kuriyama; M Yaguchi; M Nakano; K Toyama
Journal:  Ann Hematol       Date:  1995-12       Impact factor: 3.673

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.